You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Evidence-Informed Regimens

Drug and regimen monographs and information sheets for patients provide information on dosing and administering cancer treatment protocols. They are for general reference and are not meant to replace prescribing information or physician recommendations.

If you have questions about ST-QBP funding on our website, please visit our Frequently Asked Questions page.

Find enhanced Regimen Patient Information Sheets, created in collaboration with patient and family advisors.

Regimens

35 Items
Cancer Type: Breast     
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
  • Trastuzumab - Adjuvant Treatment for HER2_neu-Overexpressing Primary Breast Cancer
Evidence Building Program
  • Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer
Evidence Building Program
  • Trastuzumab (EBP) - Adjuvant Treatment for Breast Cancer Supplemental
May 2016
Cancer Type: Breast     
Intent: Adjuvant
Funding:
ODB Limited Use
  • anastrozole - An alternative to tamoxifen for the adjuvant treatment of postmenopausal women with hormone receptor positive breast cancer
May 2016
Cancer Type: Genitourinary, Prostate     
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • buserelin
ODB - General Benefit
  • bicalutamide
Oct 2016
Cancer Type: Genitourinary, Prostate     
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • bicalutamide
ODB - General Benefit
  • goserelin
Oct 2016
Cancer Type: Genitourinary, Prostate     
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
  • buserelin
Oct 2016
Cancer Type: Gastrointestinal, Hepatobiliary / Liver / Bile Duct     
Intent: Palliative
Oct 2016
Cancer Type: Gynecologic, Cervix     
Intent: Palliative
Apr 2016
Cancer Type: Genitourinary, Bladder / Urothelial     
Intent: Adjuvant, Palliative
Apr 2016
Cancer Type: Breast     
Intent: Neoadjuvant, Adjuvant
Sep 2016
Cancer Type: Breast     
Intent: Palliative
Funding:
New Drug Funding Program
    Docetaxel - Metastatic Breast Cancer
Sep 2016
Cancer Type: Sarcoma, Soft Tissue     
Intent: Neoadjuvant, Adjuvant, Palliative
Apr 2016
Cancer Type: Sarcoma, Soft Tissue     
Intent: Adjuvant
Apr 2016